Analyze Diet

Equine’s Cushing’s Disease: A Clinical Update.

Abstract: The Department of Pharmacology at the North Carolina State University College of Veterinary Medicine is currently conducting stability studies of oral suspensions of pergolide for the treatment of Cushing's disease. While those results are not available at this time, this paper summarizes the results of a literature search on possible clinical treatments for equine Cushing's and is intended to provide insight into the pathophysiology of the disease. Pharmacological options for treatment of equine Cushing's are discussed.
Publication Date: 2007-09-01 PubMed ID: 23969518
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research paper from the Department of Pharmacology at the North Carolina State University College of Veterinary Medicine summaries potential treatment options for Cushing’s disease in horses. The paper also presents an overview of the disease’s pathophysiology.

Research Overview

  • The research paper is a combined effort of the pharmacology department at North Carolina State University’s College of Veterinary Medicine. The primary focus of the study is to provide clinical updates on equine Cushing’s Disease, a common endocrine disorder in horses.

Literature Search on Treatment for Equine Cushing’s

  • In the course of the research, the authors have performed an extensive literature search focusing on potential treatments available for equine Cushing’s disease. Since no final study results were available at the time of this paper’s publication, the authors summarize the findings of numerous literary sources.
  • The literature review aims to present a thorough understanding of the current medical and pharmacological strategies employed in the treatment of Cushing’s disease in horses. The compilation of such data would facilitate comparing different medication efficiencies in dealing with the disease.

Pathophysiology of Equine’s Cushing’s Disease

  • Besides merely considering the treatment options, the paper also provides significant insights into the pathophysiology of equine Cushing’s disease. Understanding the complex interactions between different biological systems in the course of the disease helps bolster the comprehension of why certain treatments may be more beneficial than others.
  • Elucidating the pathology of this disease can potentially aid in developing novel therapeutic approaches and improving current treatment methods.

Pharmacological Therapy for Equine’s Cushing’s Disease

  • One of the significant aspects of the study is the consideration of pharmacological options for treating equine Cushing’s Disease. The ongoing stability studies of oral suspensions of pergolide constitute a part of this pharmacological treatment discussion.
  • Pergolide is a medication commonly used to manage symptoms of Parkinson’s disease in humans but has shown promise in treating equine Cushing’s Disease. The study aims to see how forms of pergolide can be used effectively in treating this disease in horses.

Cite This Article

APA
Bliss G. (2007). Equine’s Cushing’s Disease: A Clinical Update. Int J Pharm Compd, 11(5), 384-388.

Publication

ISSN: 1092-4221
NlmUniqueID: 9706294
Country: United States
Language: English
Volume: 11
Issue: 5
Pages: 384-388

Researcher Affiliations

Bliss, George
  • University of North Carolina, School of Pharmacy, Chapel Hill, North Carolina.

Citations

This article has been cited 1 times.
  1. Kirkwood NC, Hughes KJ, Stewart AJ. Pituitary Pars Intermedia Dysfunction (PPID) in Horses.. Vet Sci 2022 Oct 10;9(10).
    doi: 10.3390/vetsci9100556pubmed: 36288169google scholar: lookup